IP Library › Granted Patent US 9,999,684
Granted Patent B2
US 9,999,684 · App. 15/448,946 · Granted Jun 19, 2018

Methods of treating neurodegenerative disorders

Inventors: Victor L. Arvanian (Huntington, NY); Joel M. Levine (Miller Place, NY)
Assignee: The Research Foundation for The State University of New York
A61K48/005A61K35/76A61K38/185A61K38/51C12N7/00C12Y402/02004C12N2750/14133C12N2750/14143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,999,684
App. No.
15/448,946
Granted
Jun 19, 2018
Kind
B2
Abstract

The present disclosure is directed to adeno-associated viral vector monoclonal antibody constructs and compositions thereof, methods of improving locomotor function after spinal cord injury, methods of treating neurodegenerative diseases.

Claims (1)

1. A method of improving locomotor function after spinal cord injury in a subject in need thereof comprising the administration of AAV-rh10-NT3/chondroitinase-ABC and a pharmaceutically acceptable carrier.

Continuity (3)
Continuation 14818013 · Aug 4, 2015
Provisional Application 62032830 · Aug 4, 2014
Related Publication 20170173181A1 · Jun 22, 2017